The biggest risks lurking inside your at-home DNA and health tests

This article reviews privacy, regulatory, and consumer-safety issues with at-home direct-to-consumer DNA and health tests, highlighting that many companies are not clearly covered by HIPAA, often use broad data-sharing and research clauses (including de-identified data), and may disclose information to law enforcement when legally compelled; it also explains that CLIA/CAP lab certifications and occasional FDA authorizations do not guarantee clinical interpretation or consistent follow-up care, so consumers should read policies on data use, retention, deletion, and sample destruction before ordering tests.